MEXICO’S BIOPHARMACEUTICAL COMPANY
PROBIOMED is a Mexican biopharmaceutical enterprise oriented to research, development, manufacture and commercialization of pharmaceutical products for human health. Since our establishment, in 1970, we have worked to provide millions of people around the globe with high-technology and affordable solutions that help improve health and quality of life.
PORTFOLIO
Our portfolio is composed of a wide range of chemical synthesis generics and high-tech biosimilars -such as cytokines, monoclonal antibodies, fusion proteins and recombinant vaccines- for the prevention and treatment of autoimmune and chronic-degenerative diseases, hematological and metabolic disorders, as well as malignant neoplasms, among other conditions.
+50 YEARS WORKING FOR THE HEALTH
OF MEXICO AND THE WORLD
OF MEXICO AND THE WORLD
YOUR WELL-BEING IS OUR PRIORITY
Report any event or incident related to our medicines, vaccines or medical devices.
CORPORATE RESPONSIBILITY
In PROBIOMED we believe that our commitment goes beyond contributing to the construction of a healthier world.
LINKS OF INTEREST
